idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach
暂无分享,去创建一个
Jung-Hsin Lin | Chung-Ming Chen | Jui-Chih Wang | Pei-Ying Chu | Chung-Ming Chen | Jung-Hsin Lin | Jui-Chih Wang | P. Chu
[1] Celia A Schiffer,et al. Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor. , 2005, Journal of medicinal chemistry.
[2] PETER J. ROUSSEEUW,et al. Computing LTS Regression for Large Data Sets , 2005, Data Mining and Knowledge Discovery.
[3] Gerhard Eisenbrand,et al. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex. , 2004, European journal of biochemistry.
[4] Jung-Hsin Lin,et al. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. , 2008, Cancer research.
[5] L. Meijer,et al. Inverse in silico screening for identification of kinase inhibitor targets. , 2007, Chemistry & biology.
[6] Renxiao Wang,et al. Comparative evaluation of 11 scoring functions for molecular docking. , 2003, Journal of medicinal chemistry.
[7] Arun K. Ghosh,et al. Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M. , 2006, Journal of medicinal chemistry.
[8] M. Navre,et al. Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. , 2010, Bioorganic & medicinal chemistry letters.
[9] Arthur J. Olson,et al. Robust Scoring Functions for Protein-Ligand Interactions with Quantum Chemical Charge Models , 2011, J. Chem. Inf. Model..
[10] Ruth Nussinov,et al. SiteEngines: recognition and comparison of binding sites and protein–protein interfaces , 2005, Nucleic Acids Res..
[11] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[12] Lei Xie,et al. Structure-based systems biology for analyzing off-target binding. , 2011, Current opinion in structural biology.
[13] G. Cruciani,et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. , 2005, Journal of medicinal chemistry.
[14] Yen-Jen Oyang,et al. On the Design of Optimization Algorithms for Prediction of Molecular Interactions , 2009, 2009 Ninth IEEE International Conference on Bioinformatics and BioEngineering.
[15] Didier Rognan,et al. Ranking Targets in Structure-Based Virtual Screening of Three-Dimensional Protein Libraries: Methods and Problems , 2008, J. Chem. Inf. Model..
[16] Irene T Weber,et al. Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. , 2008, Journal of molecular biology.
[17] Didier Rognan,et al. sc-PDB: a database for identifying variations and multiplicity of 'druggable' binding sites in proteins , 2011, Bioinform..
[18] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[19] Ying Gao,et al. Bioinformatics Applications Note Sequence Analysis Cd-hit Suite: a Web Server for Clustering and Comparing Biological Sequences , 2022 .
[20] Daniel R. Caffrey,et al. Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.
[21] Irene T Weber,et al. High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains. , 2004, Journal of molecular biology.
[22] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[23] Gerard Pujadas,et al. BDT: an easy-to-use front-end application for automation of massive docking tasks and complex docking strategies with AutoDock , 2006, Bioinform..
[24] George Karypis,et al. Target Fishing for Chemical Compounds Using Target-Ligand Activity Data and Ranking Based Methods , 2009, J. Chem. Inf. Model..
[25] H. Crauwels,et al. Drug Interactions with New and Investigational Antiretrovirals , 2010, Clinical pharmacokinetics.
[26] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[27] P E Bourne,et al. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. , 1998, Protein engineering.
[28] Didier Rognan,et al. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..
[29] Gene D Morse,et al. Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] David S. Goodsell,et al. A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..
[31] Lin He,et al. SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical–protein interactome , 2009, Nucleic Acids Res..
[32] Yen-Jen Oyang,et al. MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm , 2005, Nucleic Acids Res..
[33] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[34] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[35] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[36] Zhihai Liu,et al. Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..
[37] H. van de Waterbeemd,et al. ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.
[38] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.